Clinical Trials Browser

INDUSTRY × Lymphoma, Follicular × ixazomib × Clear all

NCT01939899 2019-10-29

Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma

Phase 2 Completed

29 enrolled 26 charts

Lymphoma, Lymphoma, Follicular